We observe that the frequency of KIR2DS4 is higher in HCC patients than in non-HCC controls, although it does not reach statistical level (84.0% in HCC patients compared to 76.7% in controls, p = 0.099). This evidence concerns the gene KIR2DS4 and hepatocellular carcinoma.